These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29330173)

  • 21. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
    ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
    N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study.
    Sun J; Liu L; Shen J; Chen P; Lu H
    BMC Infect Dis; 2017 Apr; 17(1):285. PubMed ID: 28420350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in extrapulmonary tuberculosis in context of antiretroviral therapy scale-up in rural South Africa.
    Hoogendoorn JC; Ranoto L; Muditambi N; Railton J; Maswanganyi M; Struthers HE; McIntyre JA; Peters RPH
    Epidemiol Infect; 2017 Sep; 145(12):2500-2509. PubMed ID: 28748775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuberculosis seasonality in the Netherlands differs between natives and non-natives: a role for vitamin D deficiency?
    Korthals Altes H; Kremer K; Erkens C; van Soolingen D; Wallinga J
    Int J Tuberc Lung Dis; 2012 May; 16(5):639-44. PubMed ID: 22410705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical predictors of low CD4 count among HIV infected pulmonary tuberculosis clients: a health facility-based survey.
    Nzou C; Kambarami RA; Onyango FE; Ndhlovu CE; Chikwasha V
    S Afr Med J; 2010 Sep; 100(9):602-5. PubMed ID: 20822651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of antiretroviral treatment on the risk of tuberculosis during South Africa's programme expansion.
    Bachmann MO; Timmerman V; Fairall LR
    AIDS; 2015 Nov; 29(17):2261-8. PubMed ID: 26544699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculosis among adults starting antiretroviral therapy in South Africa: the need for routine case finding.
    Hanifa Y; Fielding KL; Charalambous S; Variava E; Luke B; Churchyard GJ; Grant AD
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1252-9. PubMed ID: 22794030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.
    Nakanjako D; Kiragga AN; Musick BS; Yiannoutsos CT; Wools-Kaloustian K; Diero L; Oyaro P; Lugina E; Ssali JC; Kambugu A; Easterbrook P
    AIDS; 2016 Jul; 30(12):1913-22. PubMed ID: 26959510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seasonal behavior and forecasting trends of tuberculosis incidence in Holy Kerbala, Iraq.
    Mohammed SH; Ahmed MM; Al-Mousawi AM; Azeez A
    Int J Mycobacteriol; 2018; 7(4):361-367. PubMed ID: 30531036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timing of antiretroviral therapy initiation in adults with HIV-associated tuberculosis: outcomes of therapy in an urban hospital in KwaZulu-Natal.
    Kendon MA; Knight S; Ross A; Giddy J
    S Afr Med J; 2012 Sep; 102(12):931-5. PubMed ID: 23498040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa.
    Fenner L; Reid SE; Fox MP; Garone D; Wellington M; Prozesky H; Zwahlen M; Schomaker M; Wandeler G; Kancheya N; Boulle A; Wood R; Henostroza G; Egger M;
    Trop Med Int Health; 2013 Feb; 18(2):194-8. PubMed ID: 23199369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004-12: a time series analysis.
    Nanoo A; Izu A; Ismail NA; Ihekweazu C; Abubakar I; Mametja D; Madhi SA
    Lancet Infect Dis; 2015 Sep; 15(9):1066-1076. PubMed ID: 26112077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers to antiretroviral treatment initiation in rural KwaZulu-Natal, South Africa.
    Plazy M; Newell ML; Orne-Gliemann J; Naidu K; Dabis F; Dray-Spira R
    HIV Med; 2015 Oct; 16(9):521-32. PubMed ID: 25857535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of vitamin D
    Sudfeld CR; Mugusi F; Aboud S; Nagu TJ; Wang M; Fawzi WW
    Trials; 2017 Feb; 18(1):66. PubMed ID: 28183335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of gender and income on survival and retention in a South African antiretroviral therapy programme.
    Cornell M; Myer L; Kaplan R; Bekker LG; Wood R
    Trop Med Int Health; 2009 Jul; 14(7):722-31. PubMed ID: 19413745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
    Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
    J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India.
    Alvarez-Uria G; Pakam R; Midde M; Naik PK
    J Int AIDS Soc; 2014; 17(1):19251. PubMed ID: 25499123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NIMART rollout to primary healthcare facilities increases access to antiretrovirals in Johannesburg: an interrupted time series analysis.
    Nyasulu JC; Muchiri E; Mazwi SL; Ratshefola M
    S Afr Med J; 2012 Dec; 103(4):232-6. PubMed ID: 23547688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis on spatial-temporal distribution characteristics of smear positive pulmonary tuberculosis in China, 2004-2015.
    Mao Q; Zeng C; Zheng D; Yang Y
    Int J Infect Dis; 2019 Mar; 80S():S36-S44. PubMed ID: 30825654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.